The Indian government has soft-launched nafithromycin, the first indigenously developed antibiotic, to treat patients with bacterial infections that lead to death when pathogens no longer respond to existing antibiotics. The drug, developed by Wockhardt, works against multidrug-resistant pathogens. Nafithromycin is 10 times more potent than current available options, a press release by PIB said.